Adaptimmune Therapeutics Plc (ADAPY)
0.026
0.00 (0.00%)
USD |
OTCM |
Sep 08, 16:00
Adaptimmune Therapeutics EPS Diluted (Quarterly) : -0.1163 for June 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2025 | -0.1163 |
| March 31, 2025 | -0.1859 |
| December 31, 2024 | -0.2873 |
| September 30, 2024 | -0.0696 |
| June 30, 2024 | 0.2678 |
| March 31, 2024 | -0.2004 |
| December 31, 2023 | -0.2128 |
| September 30, 2023 | -0.2003 |
| June 30, 2023 | -0.1162 |
| March 31, 2023 | 0.0063 |
| December 31, 2022 | -0.1795 |
| September 30, 2022 | -0.2512 |
| June 30, 2022 | -0.275 |
| March 31, 2022 | -0.319 |
| December 31, 2021 | -0.249 |
| September 30, 2021 | -0.2704 |
| June 30, 2021 | -0.2504 |
| March 31, 2021 | -0.2442 |
| December 31, 2020 | -0.2385 |
| Date | Value |
|---|---|
| September 30, 2020 | -0.2332 |
| June 30, 2020 | -0.2185 |
| March 31, 2020 | -0.2286 |
| December 31, 2019 | -0.283 |
| September 30, 2019 | -0.3715 |
| June 30, 2019 | -0.3898 |
| March 31, 2019 | -0.2647 |
| December 31, 2018 | -0.343 |
| September 30, 2018 | 0.0507 |
| June 30, 2018 | -0.4741 |
| March 31, 2018 | -0.2416 |
| December 31, 2017 | -0.3041 |
| September 30, 2017 | -0.0094 |
| June 30, 2017 | -0.2427 |
| March 31, 2017 | -0.3029 |
| December 31, 2016 | -0.2389 |
| September 30, 2016 | -0.2399 |
| June 30, 2016 | -0.2968 |
| March 31, 2016 | -0.2377 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Oxford Biomedica Plc | -- |
| Kiniksa Pharmaceuticals International Plc | 0.305 |
| Autolus Therapeutics Plc | -0.1472 |
| Bicycle Therapeutics Plc | -0.7224 |
| Barinthus Biotherapeutics Plc | -0.2595 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -30.72M |
| Revenue (Quarterly) | 13.85M |
| Total Expenses (Quarterly) | 44.56M |